Phospholipid-based Immobilized Artificial Membrane (IAM) Chromatography: A Powerful Tool to Model Drug Distribution Processes

被引：10
|
作者：
Sobanska, Anna W. [1 ]
Brzezinska, Elzbieta [1 ]
机构：
[1] Med Univ Lodz, Dept Analyt Chem, Ul Muszynskiego 1, PL-90151 Lodz, Poland
来源：
CURRENT PHARMACEUTICAL DESIGN | 2017年 / 23卷 / 44期
关键词：
IAM chromatography; blood-brain barrier; skin permeability; oral bioavailability; BLOOD-BRAIN-BARRIER; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN SERUM-ALBUMIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN INTESTINAL-ABSORPTION; STRUCTURALLY DIVERSE DRUGS; THIN-LAYER-CHROMATOGRAPHY; GRADIENT HPLC METHOD; PARTITION-COEFFICIENTS; POLAR INTERACTIONS;
D O I：
10.2174/1381612823666171018114331
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A review of applications of the Immobilized Artificial Membrane (IAM) chromatography in drug discovery is given. IAM chromatography is presented as a tool to predict the interactions of solutes with biomembranes, blood-brain barrier permeability, volume of distribution, oral and skin absorption of drugs and compared to other in vitro techniques used to study drug bioavailability (caco-2 cells, liposome partition). Unbound phosphatidylcholine based stationary phases are also discussed. Some new trends and ideas in the IAM chromatography are presented.
引用
收藏
页码：6784 / 6794
页数：11
相关论文
共 50 条
  • [1] Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery
    Tsopelas, Fotios
    Vallianatou, Theodosia
    Tsantili-Kakoulidou, Anna
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (05) : 473 - 488
  • [2] Recent developments in the application of immobilized artificial membrane (IAM) chromatography to drug discovery
    Tsopelas, Fotios
    Vallianatou, Theodosia
    Tsantili-Kakoulidou, Anna
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (09) : 1087 - 1098
  • [3] Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs
    Valko, Klara
    Rava, Silvia
    Bunally, Shenaz
    Anderson, Scott
    ADMET AND DMPK, 2020, 8 (01): : 78 - 97
  • [4] Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors
    Yen, TE
    Agatonovic-Kustrin, S
    Evans, AM
    Nation, RL
    Ryand, J
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 38 (03) : 472 - 478
  • [5] Immobilized artificial membrane (IAM) chromatography with cyclodextrin-modified mobile phases
    Armstrong, Ariel S.
    Coym, Jason W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [6] Immobilized artificial membrane (IAM) technology - A tool for predicting drug permeability through the blood-brain barrier
    Reichel, A
    Begley, DJ
    Abbott, NJ
    JOURNAL OF PHYSIOLOGY-LONDON, 1996, 491P : P30 - P30
  • [7] Predicting membrane permeability of small molecule drugs using immobilized artificial membrane (IAM) chromatography
    Szczerba, T
    LC GC NORTH AMERICA, 2003, : 50 - 50
  • [8] IMMOBILIZED ARTIFICIAL MEMBRANE (IAM) CHROMATOGRAPHY FOR ANALYSIS OF BILIARY VESICLE-ASSOCIATED PROTEINS
    SECKNUS, R
    YAMASHITA, G
    CORRADINI, SG
    CHERNOSKY, A
    KRIVACIC, K
    HOLZBACH, RT
    GASTROENTEROLOGY, 1995, 108 (04) : A1165 - A1165
  • [9] Development of the first sphingomyelin biomimetic stationary phase for immobilized artificial membrane (IAM) chromatography
    Verzele, Dieter
    Lynen, Frederic
    De Vrieze, Mike
    Wright, Adrian G.
    Hanna-Brown, Melissa
    Sandra, Pat
    CHEMICAL COMMUNICATIONS, 2012, 48 (08) : 1162 - 1164
  • [10] Drug-Membrane Interaction on Immobilized Liposome Chromatography Compared to Immobilized Artificial Membrane (IAM), Liposome/Water, and Octan-1-ol/Water Systems
    Liu, Xiangli
    Fan, Ping
    Chen, Ming
    Hefesha, Hossam
    Scriba, Gerhard K. E.
    Gabel, Detlef
    Fahr, Alfred
    HELVETICA CHIMICA ACTA, 2010, 93 (02) : 203 - 211
12345